InvestorsHub Logo
Followers 119
Posts 7889
Boards Moderated 0
Alias Born 09/02/2011

Re: trademax42 post# 16534

Tuesday, 03/21/2017 10:32:24 PM

Tuesday, March 21, 2017 10:32:24 PM

Post# of 73619
Cannabis Provisional Patent #62466209, a provisional patent for delivering medical marijuana /cannabis to the body by applying the medication onto the skin in an ointment base topical solution.

Think about it, Viabecline has been more than 96% effective in healing diabetic foot ulcers within 4 weeks over its closest competitor. If tests results are similar to Viabecline, for the MMJ space, do you think any other product on the planet will be able to compete with them?
We are talking $$'s when this happens, or a big buyout!

www.marketwired.com/press-release/viaderma-receives-provisional-patent-numbers-its-fda-registered-viabecline-cannabis-otc-pink-vdrm-2203945.htm

ViaDerma Receives Provisional Patent Numbers for Its FDA Registered Viabecline and Cannabis Technologies, and Seeks to Distribute its Products with a Management, Marketing and Distribution Company in Canada to Approved International Cannabis Countries

The Company will Target Countries where Medical and Recreational Cannabis Sales are Legal and Accepted and Scientific Research is Allowed.

The Company has signed a LOI or letter of intent to work with a Canadian-based investment group with expertise in logistics that includes distribution for the new and anticipated products. The investment group will target sales for the new patent pending products to countries that have accepted "Medical Marijuana" and "Recreational Use" of cannabis products and technologies for delivery of CBD and THC. This group will also target countries that allow the "Clinical Studies" for medical testing such as the United Kingdom and other Asian countries.

All these companies will want licensing agreements for the Cannabis Provisional Patent #62466209

Canopy Growth (TSX:WEED)
OrganiGram (TSXV:OGI)
THC Biomed Intl Ltd (CSNX:THC)
Maple Leaf Green World (TSXV:MGW)
Emerald Health Therapeutics (TSXV:EMH)
Tetra Bio-Pharma (CSNX:TBP)
PharmaCan Capital (TSXV:MJN)
Aphria (TSXV:APH)
Aurora Cannabis (CSNX:ACB)
Cannabix Technologies (CSNX:BLO)
Supreme Pharmaceuticals (CSNX:SL)
Mettrum Health (TSXV:MT)
MYM Nutraceuticals (CSE:MYM)
CannaRoyalty (CSE:CRZ)
Emblem (TSXV:EMC)
Liberty Leaf (CSE:LIB)
Valens GroWorks (CSE:VGW)
Marapharm Ventures (CSE:MDM)
Wildflower Marijuana (CSE:SUN)
True Leaf Pet (CSE:MJ)
Puf Ventures (CSE:PUF)
Cannabix (CSE:BLO)